Avista Healthcare Partners Acquires EBI Bone Healing Division from Highridge Medical

Envista Acquires Osteogenics Biomedical Business

May 17, 2022

Medical Devices

Envista Holdings Corporation entered into a definitive agreement to acquire Osteogenics Biomedical, Allotech LLC and OBI Biologics (collectively “Osteogenics”), a developer of regenerative dental bone grafting products sold primarily under the Cytoplast brand. The deal, subject to customary regulatory approvals and expected to close in the third quarter, expands Envista’s capabilities in regenerative solutions for periodontists, oral and maxillofacial surgeons and implant dentistry; the transaction is not subject to a financing condition or shareholder vote.

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.

H.I.G. Capital Acquires ZimVie's Spine Business, Rebrands as Highridge Medical

April 1, 2024

Medical Devices

An affiliate of H.I.G. Capital has completed the acquisition of the Spine division of ZimVie, Inc. The acquired business will operate independently under the new name Highridge Medical, headquartered in Westminster, Colorado, and H.I.G. plans to invest in R&D, product innovation and strategic growth to build a leading privately held spine platform.

Venture Life Group plc Acquires BBI Healthcare (BBIH) from Exponent

June 7, 2021

Consumer Products

Venture Life Group plc has agreed to acquire BBI Healthcare (BBIH), the consumer self-care division of BBI Group, from private equity owner Exponent. BBIH — owner of brands including Balance Activ, GlucoGel and LIFT with broad UK retail distribution and a Swedish manufacturing facility — was transformed under Exponent, delivering strong EBITDA growth; its managing director will leave on completion while the chairman will remain with BBI Group.

Avista Capital Partners Invests in eMolecules

March 25, 2021

Healthcare Services

Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.

Avista Capital Partners Acquires Spear Education

December 19, 2022

Healthcare Services

Avista Capital Partners has acquired Spear Education, a Scottsdale-based provider of digital and in-person clinical training, practice analytics, and consulting solutions for the dental market, from Linden Capital Partners. Transaction terms were not disclosed; Avista said it will leverage its healthcare technology and dental sector experience to accelerate Spear's growth and expand its digital and membership offerings.